ヌクレオシド代謝拮抗剤とmRNAのハイブリッドモダリティによる抗ウイルス創薬

• Project/Area Number: 25K18596
• Research Category: Grant-in-Aid for Early-Career Scientists
• Allocation Type: Multi-year Fund
• Review Section: Basic Section 47010:Pharmaceutical chemistry and drug development sciences-related
• Research Institution: The University of Tokushima
• Principal Investigator: 月本 準 徳島大学, 大学院医歯薬学研究部(薬学域), 特任助教 (70966671)
• Project Period (FY): 2025-04-01 – 2027-03-31
• Project Status: Adopted (Fiscal Year 2025)
• Budget Amount: ¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000); Fiscal Year 2026: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000); Fiscal Year 2025: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)